Determination of rivaroxaban by utilizing its quenching effect on acetoxymercuric fluorescein reagent in pharmaceutical preparations and in spiked biological matrices

Spectrochim Acta A Mol Biomol Spectrosc. 2023 Feb 15;287(Pt 2):122125. doi: 10.1016/j.saa.2022.122125. Epub 2022 Nov 17.

Abstract

A simple, precise and inexpensive spectrofluorimetric method has been developed for assay of rivaroxaban raw material and its tablets. The method depends on the quenching effect of rivaroxaban on the fluorescence intensity of acetoxymercuric fluorescein (AMF). Parameters that may affect the reaction such as pH, AMF solution concentration, reaction time and diluting solvents were studied and optimized. The proposed method was applied for determination of rivaroxaban in tablets with percentage recovery of 100.4 ± 0.28, and in organic extract of spiked plasma samples with percentage recovery of 98.40 ± 1.08. The developed method was validated according to ICH guidelines in terms of accuracy, precision, linearity, range, limit of detection (LOD) and limit of quantification (LOQ).

Keywords: Acetoxymercuric fluorescein; Quenching effect; Rivaroxaban; spectrofluorimetric.

MeSH terms

  • Biological Assay*
  • Fluorescein
  • Indicators and Reagents
  • Pharmaceutical Preparations
  • Rivaroxaban*

Substances

  • Indicators and Reagents
  • Fluorescein
  • Rivaroxaban
  • Pharmaceutical Preparations